Swedish Orphan Biovitrum ... (BIOVF)

PNK: BIOVF · Real-Time Price · USD

30.66

0.00 (0.00%)

At close: Apr 30, 2025, 10:30 AM

Swedish Orphan Biovitrum AB (publ) Cash Flow Statement

Financials in SEK. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Net Income	4.41B	2.95B	3.32B	3.29B	3.25B	3.3B	2.42B	1.15B	809.07M
Depreciation & Amortization	3.68B	3.2B	2.42B	2.01B	2.02B	1.59B	484.57M	485.98M	440.71M
Stock-Based Compensation	n/a	n/a	268M	154M	114M	80M	46M	39.6M	31.69M
Other Working Capital	-179M	1M	1M	980M	1.07B	1.22B	-19.62M	85.17M	-205.41M
Other Non-Cash Items	-519M	-524M	-269M	-945M	-351M	-417M	-503.92M	-416.84M	-798.63M
Deferred Income Tax	n/a	n/a	-268M	-154M	367M	744M	-103.4M	173.64M	159.61M
Change in Working Capital	-179M	-1.16B	-806M	1.11B	-184M	-1.67B	-250.47M	-98.05M	-299.6M
Operating Cash Flow	7.39B	4.47B	4.67B	5.47B	5.21B	3.63B	2.09B	1.33B	342.86M
Capital Expenditures	-3B	-4.94B	-1.48B	-370M	-3.85B	-9.75B	-577.88M	-139.44M	-164.47M
Cash Acquisitions	n/a	-16.96B	n/a	3M	8M	-12.88B	3.22M	1.2M	6.55M
Purchase of Investments	n/a	n/a	n/a	n/a	-120M	n/a	-700K	-737K	-100K
Sales Maturities Of Investments	n/a	n/a	n/a	n/a	-8M	n/a	n/a	n/a	n/a
Other Investing Acitivies	-2.92B	-4.54B	-1.41B	-320M	8M	941M	3.04M	1.2M	6.55M
Investing Cash Flow	-3.09B	-21.9B	-1.48B	-367M	-3.96B	-21.68B	-575.54M	-138.98M	-158.01M
Debt Repayment	-4.44B	11.25B	-2.42B	-4B	-1.45B	15.87B	-2M	-500M	-331.09M
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	8M	-365M	-572M	-476M	170M	-94M	n/a	n/a	n/a
Financial Cash Flow	-4B	17.01B	-2.99B	-4.47B	-1.57B	15.78B	-2.05M	-500M	-307.59M
Net Cash Flow	236M	-457M	316M	641M	-333M	-2.26B	1.52B	692.71M	-117.87M
Free Cash Flow	4.38B	-473M	3.19B	5.1B	1.36B	-6.11B	1.51B	1.19B	178.39M